Damian McNamara is a journalist for Medscape Medical News and MDedge. He worked full-time for MDedge as the Miami Bureau covering a dozen medical specialties during 2001-2012, then as a freelancer for Medscape and MDedge, before being hired on staff by Medscape in 2018. Now the two companies are one. He uses what he learned in school – Damian has a BS in chemistry and an MS in science, health and environmental reporting/journalism. He works out of a home office in Miami, with a 100-pound chocolate lab known to snore under his desk during work hours.
News
Surge in colonoscopies postponed by COVID-19 expected
Experts share concerns and advice for navigating an anticipated wave of colorectal cancer screening patients returning after the pandemic.
News
FDA revokes emergency use of hydroxychloroquine
The agency determined that chloroquine and hydroxychloroquine are unlikely to be effective against COVID-19.
News
Surge in colonoscopies postponed by COVID-19 expected
Experts share concerns and advice for navigating an anticipated wave of colorectal cancer screening patients returning after the pandemic.
News
ACR reacts to study disclosing industry donations
A new national database allows researchers for the first time to quantify and evaluate details of industry support to leaders of prominent medical...
News
Cardiology societies unite to denounce racist violence
The death of George Floyd and other African Americans at the hands of police prompted the Association of Black Cardiologists, AHA, and ACC to...
News
NIMH strategic plan returns balance to research priorities
The NIMH’s strategic plan renews and expands a focus on suicide prevention, early intervention in psychosis, and the needs of diverse populations...
News
Food allergies in children less frequent than expected
Forty-six children underwent food challenge.
News
Placental injury reported in women with COVID-19
A first-of-its-kind study looks at the extent and implications of pathological damage to the placentas of mothers with COVID-19.
News
Mixed results for aducanumab in two phase 3 trials for Alzheimer’s disease
One of two “identical studies” assessing a novel treatment in development for Alzheimer’s disease reports significant efficacy, while the other...
News
Galcanezumab looks promising for treatment-resistant migraine
The monoclonal antibody reduced the mean number of monthly migraine days in a 3-month open-label extension of the phase 3 CONQUER study.
News
Natalizumab bests fingolimod for relapsing-remitting MS
More patients taking natalizumab versus fingolimod reached NEDA at one year.
News
Predictors of ICH after thrombectomy identified
The sum of three variables may predict which patients undergoing thrombectomy up to 24 hours after a stroke are at higher risk of developing...
News
Trials and tribulations: Neurology research during COVID-19
Many researchers have redesigned their studies, at least in part to optimize the safety of their participants and research staff.
News
Two rare neurologic conditions linked to COVID-19
Two variants of Guillain-Barré syndrome—Miller Fisher syndrome and polyneuritis cranialis—have been linked with COVID-19 infection.